Flottmann, Fabian http://orcid.org/0000-0001-8358-8089
,
Broocks, Gabriel
Faizy, Tobias Djamsched
McDonough, Rosalie
Watermann, Lucas
Deb-Chatterji, Milani
Thomalla, Götz
Herzberg, Moriz
Nolte, Christian H.
Fiehler, Jens
Leischner, Hannes
Brekenfeld, Caspar
Funding for this research was provided by:
Universitätsklinikum Hamburg-Eppendorf (UKE)
Article History
Received: 16 October 2019
Accepted: 23 January 2020
First Online: 17 February 2020
Conflict of interest
: G. Thomalla serves as a consultant or speaker for Acandis, Bayer Healthcare, Boehringer Ingelheim, BristolMyersSquibb/Pfizer, Covidien, Glaxo Smith Kline; served as a lead investigator of the WAKE-UP study; Principal Investigator of the THRILL study; received grants by the European Union (Grant No. 278276 und 634809) and Deutsche Forschungsgemeinschaft (SFB 936, Projekt C2). C.H. Nolte reports consulting and lecture fess from Boehringer Ingelheim, W.L. Gore and Associates, Bristol-Myers Squibb, Pfizer, and Sanofi, all outside of the submitted work. J. Fiehler served as a consultant for Acandis, Boehringer Ingelheim, Codman, Microvention, Sequent, Stryker. Speaker for Bayer Healthcare, Bracco, Covidien/ev3, Penumbra, Philips, Siemens. Received grants from Bundesministeriums für Wirtschaft und Energie (BMWi), Bundesministerium für Bildung und Forschung (BMBF), Deutsche Forschungsgemeinschaft (DFG), European Union (EU), Covidien, Stryker (THRILL study), Microvention (ERASER study). F. Flottmann, G. Broocks, T.D. Faizy, R. McDonough, L. Watermann, M. Deb-Chatterji, M. Herzberg, H. Leischner and C. Brekenfeld declare that they have no competing interests.